Cognition Therapeutics, Inc. (CGTX)

NASDAQ: CGTX · IEX Real-Time Price · USD

1.930

-0.050 (-2.53%)

At close: May 3, 2024, 4:00 PM

2.020

+0.090 (4.66%)

After-hours: May 3, 2024, 7:55 PM EDT

Cognition Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-25.79	-21.4	-16.25	-12.07	-8.76
Depreciation & Amortization	0.25	0.24	0.09	0.1	0.08
Share-Based Compensation	4.35	3.57	5.18	0.48	0.36
Other Operating Activities	5.16	-0.94	2.81	3.83	1.3
Operating Cash Flow	-16.02	-18.53	-3.63	-3.43	-3.1
Capital Expenditures	-0.15	-0.17	-0.03	-0.01	-0.14
Investing Cash Flow	-0.15	-0.17	-0.03	-0.01	-0.14
Share Issuance / Repurchase	5.33	6.94	44.53	0.05	0
Debt Issued / Paid	-0.81	-1.4	8.67	5.81	2.83
Other Financing Activities	-	-	-	-0.09	-0.03
Financing Cash Flow	4.52	5.55	53.2	5.77	2.79
Exchange Rate Effect	0	-0	-0.01	-0.02	-0.06
Net Cash Flow	-11.64	-13.16	49.53	2.3	-0.51
Free Cash Flow	-16.17	-18.7	-3.66	-3.44	-3.24
Free Cash Flow Per Share	-0.54	-0.79	-0.70	-6.78	-2.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).